The Journal of Neuroscience, August 10, 2005, 25(32):7459-7469; doi:10.1523/JNEUROSCI.1193-05.2005
Previous Article | Next Article 
Behavioral/Systems/Cognitive
Cholecystokinin Activates Orexin/Hypocretin Neurons through the Cholecystokinin A Receptor
Natsuko Tsujino,1 *
Akihiro Yamanaka,1,3 *
Kanako Ichiki,1
Yo Muraki,1
Thomas S. Kilduff,4
Ken-ichi Yagami,2
Satoru Takahashi,2
Katsutoshi Goto,1 and
Takeshi Sakurai1,3
1Department of Molecular Pharmacology, Graduate School of Comprehensive Human Sciences, and 2Laboratory Animal Resource Center, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan, 3Exploratory Research for Advanced Technology Yanagisawa Orphan Receptor Project, Japan Science and Technology Corporation, Tokyo 135-0064, Japan, and 4Molecular Neurobiology Laboratory, SRI International, Menlo Park, California 94025
Orexin A and B are neuropeptides implicated in the regulation of sleep/wakefulness and energy homeostasis. The regulatory mechanism of the activity of orexin neurons is not precisely understood. Using transgenic mice in which orexin neurons specifically express yellow cameleon 2.1, we screened for factors that affect the activity of orexin neurons (a total of 21 peptides and six other factors were examined) and found that a sulfated octapeptide form of cholecystokinin (CCK-8S), neurotensin, oxytocin, and vasopressin activate orexin neurons. The mechanisms that underlie CCK-8S-induced activation of orexin neurons were studied by both calcium imaging and slice patch-clamp recording. CCK-8S induced inward current in the orexin neurons. The CCKA receptor antagonist lorglumide inhibited CCK-8S-induced activation of orexin neurons, whereas the CCKB receptor agonists CCK-4 (a tetrapeptide form of cholecystokinin) and nonsulfated CCK-8 had little effect. The CCK-8S-induced increase in intracellular calcium concentration was eliminated by removing extracellular calcium but not by an addition of thapsigargin. Nifedipine,
-conotoxin,
-agatoxin, 4-ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium chloride, and SNX-482 had little effect, but La3+, Gd3+, and 2-aminoethoxydiphenylborate inhibited CCK-8S-induced calcium influx. Additionally, the CCK-8S-induced inward current was dramatically enhanced in the calcium-free solution and was inhibited by the cation channel blocker SKF96365 suggesting an involvement of extracellular calcium-sensitive cation channels. CCK-8S did not induce an increase in intracellular calcium concentration when membrane potential was clamped at -60 mV, suggesting that the calcium increase is induced by depolarization. The evidence presented here expands our understanding of the regulation of orexin neurons and the physiological role of CCK in the CNS.
Key words: orexin; hypocretin; patch clamp; transgenic; cholecystokinin; CCKAR
Received March 28, 2005;
revised July 4, 2005;
accepted July 4, 2005.
This article has been cited by other articles:

|
 |

|
 |
 
L. Chung and S. D. Moore
Cholecystokinin Excites Interneurons in Rat Basolateral Amygdala
J Neurophysiol,
July 1, 2009;
102(1):
272 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tsujino and T. Sakurai
Orexin/Hypocretin: A Neuropeptide at the Interface of Sleep, Energy Homeostasis, and Reward System
Pharmacol. Rev.,
June 1, 2009;
61(2):
162 - 176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hara, D. Gerashchenko, J. P. Wisor, T. Sakurai, X. Xie, and T. S. Kilduff
Thyrotropin-Releasing Hormone Increases Behavioral Arousal through Modulation of Hypocretin/Orexin Neurons
J. Neurosci.,
March 25, 2009;
29(12):
3705 - 3714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Matsuki, M. Nomiyama, H. Takahira, N. Hirashima, S. Kunita, S. Takahashi, K.-i. Yagami, T. S. Kilduff, B. Bettler, M. Yanagisawa, et al.
Selective loss of GABAB receptors in orexin-producing neurons results in disrupted sleep/wakefulness architecture
PNAS,
March 17, 2009;
106(11):
4459 - 4464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Rao, M. Lu, F. Ge, D. J. Marsh, S. Qian, A. H. Wang, M. R. Picciotto, and X.-B. Gao
Regulation of Synaptic Efficacy in Hypocretin/Orexin-Containing Neurons by Melanin Concentrating Hormone in the Lateral Hypothalamus
J. Neurosci.,
September 10, 2008;
28(37):
9101 - 9110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tsunematsu, L.-Y. Fu, A. Yamanaka, K. Ichiki, A. Tanoue, T. Sakurai, and A. N. van den Pol
Vasopressin Increases Locomotion through a V1a Receptor in Orexin/Hypocretin Neurons: Implications for Water Homeostasis
J. Neurosci.,
January 2, 2008;
28(1):
228 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Giacobini and S. Wray
Cholecystokinin Directly Inhibits Neuronal Activity of Primary Gonadotropin-Releasing Hormone Cells through Cholecystokinin-1 Receptor
Endocrinology,
January 1, 2007;
148(1):
63 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. O. Alberto, R. B. Trask, M. E. Quinlan, and M. Hirasawa
Bidirectional Dopaminergic Modulation of Excitatory Synaptic Transmission in Orexin Neurons
J. Neurosci.,
September 27, 2006;
26(39):
10043 - 10050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Xie, T. L. Crowder, A. Yamanaka, Stephen. R. Morairty, R. D. LeWinter, T. Sakurai, and T. S. Kilduff
GABAB receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus
J. Physiol.,
July 15, 2006;
574(2):
399 - 414.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Yamanaka, Y. Muraki, K. Ichiki, N. Tsujino, T. S. Kilduff, K. Goto, and T. Sakurai
Orexin Neurons Are Directly and Indirectly Regulated by Catecholamines in a Complex Manner
J Neurophysiol,
July 1, 2006;
96(1):
284 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-Y. Deng and S. Lei
Bidirectional modulation of GABAergic transmission by cholecystokinin in hippocampal dentate gyrus granule cells of juvenile rats
J. Physiol.,
April 15, 2006;
572(2):
425 - 442.
[Abstract]
[Full Text]
[PDF]
|
 |
|